A Dark Vector Cognition product

Item 16. FORM 10-K SUMMARY

5K characters. Original on sec.gov · Markdown

Item 16. FORM 10-K SUMMARY

Not applicable.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Keurig Dr Pepper Inc.
By:/s/ Sudhanshu Priyadarshi
Name:Sudhanshu Priyadarshi
Title:Chief Financial Officer of Keurig Dr Pepper Inc.
(Principal Financial Officer)
Date:February 23, 2023

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

By:/s/ Robert J. GamgortBy:/s/ Sudhanshu Priyadarshi
Name:Robert J. GamgortName:Sudhanshu Priyadarshi
Title:Chief Executive Officer, President and Executive Chairman of the Board of DirectorsTitle:Chief Financial Officer
Keurig Dr Pepper Inc.Keurig Dr Pepper Inc.
Date:February 23, 2023Date:February 23, 2023
By:/s/ Angela A. StephensBy:/s/ Oray Boston
Name:Angela A. StephensName:Oray Boston
Title:Senior Vice President and ControllerTitle:Director
(Principal Accounting Officer)
Date:February 23, 2023Date:February 23, 2023
By:/s/ Michael CallBy:/s/ Olivier Goudet
Name:Michael CallName:Olivier Goudet
Title:DirectorTitle:Director
Date:February 23, 2023Date:February 23, 2023
By:/s/ Peter HarfBy:/s/ Juliette Hickman
Name:Peter HarfName:Juliette Hickman
Title:DirectorTitle:Director
Date:February 23, 2023Date:February 23, 2023
By:/s/ Paul S. MichaelsBy:/s/ Pamela Patsley
Name:Paul S. MichaelsName:Pamela Patsley
Title:DirectorTitle:Director
Date:February 23, 2023Date:February 23, 2023
By:/s/ Lubomira RochetBy:/s/ Debra Sandler
Name:Lubomira RochetName:Debra Sandler
Title:DirectorTitle:Director
Date:February 23, 2023Date:February 23, 2023
By:/s/ Robert SingerBy:/s/ Larry Young
Name:Robert SingerName:Larry Young
Title:DirectorTitle:Director
Date:February 23, 2023Date:February 23, 2023

Previous: Item 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES